When was MOLNLYCKE HEALTH CARE founded?

MOLNLYCKE HEALTH CARE was founded on 30 Jan 1998, making it 28 years old.

Is MOLNLYCKE HEALTH CARE still active?

Yes, MOLNLYCKE HEALTH CARE is currently active.

Where is MOLNLYCKE HEALTH CARE registered?

MOLNLYCKE HEALTH CARE's registered address is Chaussée Romaine (War) 176, 4300 Waremme, Belgium.

How many employees does MOLNLYCKE HEALTH CARE have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), MOLNLYCKE HEALTH CARE reported 299.5 full-time equivalent employees.

What is MOLNLYCKE HEALTH CARE's annual turnover?

MOLNLYCKE HEALTH CARE's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €123,219,725.

Did MOLNLYCKE HEALTH CARE make a profit or a loss?

MOLNLYCKE HEALTH CARE's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €7,859,016.

When did MOLNLYCKE HEALTH CARE last file annual accounts?

MOLNLYCKE HEALTH CARE's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is MOLNLYCKE HEALTH CARE B Corp certified?

We have no B Corp certification on file for MOLNLYCKE HEALTH CARE.

Does MOLNLYCKE HEALTH CARE hold Fairtrade certification?

No, MOLNLYCKE HEALTH CARE does not currently hold Fairtrade certification.

MOLNLYCKE HEALTH CARE

Q: What does MOLNLYCKE HEALTH CARE do?

MOLNLYCKE HEALTH CARE's registered main activities are Manufacture of other pharmaceutical products, Manufacture of medical and dental instruments and supplies, Wholesale of wiring devices, including installation equipment, Wholesale of household linen and bed linen, Wholesale of pharmaceutical and medical goods, Wholesale of clothing, other than workwear and underwear, Wholesale trade of thread, Wholesale of perfume and cosmetics, Market research and public opinion polling, and Wholesale trade of medical, surgical and dental supplies.

BE 0462.556.475

Copied!

NV/SA

Status

Active

Founded

30 Jan 1998

Size

Large · 299.5 FTE

Age

28 yrs

Main activity

Manufacture of other pharmaceutical products

Activities

10 activities

Manufacture of other pharmaceutical productsManufacture of medical and dental instruments and suppliesWholesale of wiring devices, including installation equipmentWholesale of household linen and bed linenWholesale of pharmaceutical and medical goodsWholesale of clothing, other than workwear and underwearWholesale trade of threadWholesale of perfume and cosmeticsMarket research and public opinion pollingWholesale trade of medical, surgical and dental supplies

Financials

Turnover2025

€123M-11.4%

Profit / Loss2025

€7.9M+10.2%

Equity2025

€14.5M+3.7%

2025	2024	2023	2022
€123,219,725-11.4%	€139,082,750+3.4%	€134,532,319-0.1%	€134,623,404
€7,859,016+10.2%	€7,133,725-15.8%	€8,470,097+104.8%	€4,136,795
€14,456,632+3.7%	€13,947,616+17.8%	€11,842,947+251.1%	€3,372,850
€27,616,300-7.9%	€29,998,008+5.5%	€28,442,276-33.5%	€42,804,037
—	—	€0	€0
299.5-0.3%	300.3-4.8%	315.3-7.6%	341.4
€411,418-11.2%	€463,146+8.5%	€426,680+8.2%	€394,327

Frequently asked questions

01What is MOLNLYCKE HEALTH CARE's official registered name?

MOLNLYCKE HEALTH CARE.

02What is MOLNLYCKE HEALTH CARE's enterprise number (VAT number)?

BE 0462.556.475.

03What is MOLNLYCKE HEALTH CARE's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€123,219,725-11.4%	€139,082,750+3.4%	€134,532,319-0.1%	€134,623,404
	€27,649,138-2.3%	€28,309,336+1.8%	€27,799,507-7.3%	€30,004,778
	€11,226,853+9.4%	€10,262,874-11.8%	€11,642,314+74.5%	€6,670,410
	€13,799,880	—	—	€9,156,775
	€7,859,016+10.2%	€7,133,725-15.8%	€8,470,097+104.8%	€4,136,795
	€1,864,306-42.5%	€3,241,858+16%	€2,795,521+315.8%	€672,265
Profitability
	11.2%	—	—	6.8%
	6.4%+24.4%	5.1%-18.5%	6.3%+104.9%	3.1%
	54.4%+6.3%	51.1%-28.5%	71.5%-41.7%	122.6%
	18.7%+15.1%	16.2%-22.8%	21.0%+134.7%	9.0%
Solvency
	€42,072,932-4.3%	€43,945,624+9.1%	€40,285,224-12.8%	€46,176,887
	€10,174,655+25%	€8,141,375-7.1%	€8,765,826-13.1%	€10,083,117
	€438,733-3%	€452,403-49.2%	€890,148-45.7%	€1,639,524
	€14,456,632+3.7%	€13,947,616+17.8%	€11,842,947+251.1%	€3,372,850
	34.4%+8.3%	31.7%+8%	29.4%+302.5%	7.3%
	€6,000,0000%	€6,000,0000%	€6,000,0000%	€6,000,000
	0.42-3.5%	0.43-15.1%	0.51-71.5%	1.78
	€27,616,300-7.9%	€29,998,008+5.5%	€28,442,276-33.5%	€42,804,037
	1.91-11.2%	2.15-10.4%	2.40-81.1%	12.69
	25.34+29.4%	19.59-20.3%	24.57+24.7%	19.71
Liquidity
	—	—	€0	€0
	€5,242,546-23.6%	€6,865,746+8.9%	€6,303,536-28.1%	€8,769,723
	€20,016,645-6.1%	€21,319,745-10.9%	€23,921,459-4.6%	€25,067,452
	€6,816,705-33.1%	€10,196,707-15%	€12,000,661-35.9%	€18,722,992
	€21,616,300-9.9%	€23,998,008+6.9%	€22,442,276-39%	€36,804,037
	1.46-1.2%	1.47+7.9%	1.36+45.8%	0.94
	€9,843,244-13.3%	€11,353,838+38.7%	€8,186,973+448.4%	-€2,349,791
Efficiency
	59 days+6%	56 days-13.8%	65 days-4.5%	68 days
	26 days-20.2%	32 days-18.1%	39 days-30.7%	57 days
	23 days-8.7%	26 days+2.5%	25 days-18.7%	31 days
	13.53-9%	14.87+21.6%	12.23-8.5%	13.36
Profit appropriation
	€7,350,000+47.1%	€4,998,000	—	€4,140,500
	€306,2500%	€306,2500%	€306,2500%	€306,250
	€11,087,882+4.8%	€10,578,866+24.8%	€8,474,197>1000%	€4,100

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€123,219,725-11.4%	€139,082,750+3.4%	€134,532,319-0.1%	€134,623,404
	€27,649,138-2.3%	€28,309,336+1.8%	€27,799,507-7.3%	€30,004,778
	€11,226,853+9.4%	€10,262,874-11.8%	€11,642,314+74.5%	€6,670,410
	€13,799,880	—	—	€9,156,775
	€7,859,016+10.2%	€7,133,725-15.8%	€8,470,097+104.8%	€4,136,795
	€1,864,306-42.5%	€3,241,858+16%	€2,795,521+315.8%	€672,265
Profitability
	11.2%	—	—	6.8%
	6.4%+24.4%	5.1%-18.5%	6.3%+104.9%	3.1%
	54.4%+6.3%	51.1%-28.5%	71.5%-41.7%	122.6%
	18.7%+15.1%	16.2%-22.8%	21.0%+134.7%	9.0%
Solvency
	€42,072,932-4.3%	€43,945,624+9.1%	€40,285,224-12.8%	€46,176,887
	€10,174,655+25%	€8,141,375-7.1%	€8,765,826-13.1%	€10,083,117
	€438,733-3%	€452,403-49.2%	€890,148-45.7%	€1,639,524
	€14,456,632+3.7%	€13,947,616+17.8%	€11,842,947+251.1%	€3,372,850
	34.4%+8.3%	31.7%+8%	29.4%+302.5%	7.3%
	€6,000,0000%	€6,000,0000%	€6,000,0000%	€6,000,000
	0.42-3.5%	0.43-15.1%	0.51-71.5%	1.78
	€27,616,300-7.9%	€29,998,008+5.5%	€28,442,276-33.5%	€42,804,037
	1.91-11.2%	2.15-10.4%	2.40-81.1%	12.69
	25.34+29.4%	19.59-20.3%	24.57+24.7%	19.71
Liquidity
	—	—	€0	€0
	€5,242,546-23.6%	€6,865,746+8.9%	€6,303,536-28.1%	€8,769,723
	€20,016,645-6.1%	€21,319,745-10.9%	€23,921,459-4.6%	€25,067,452
	€6,816,705-33.1%	€10,196,707-15%	€12,000,661-35.9%	€18,722,992
	€21,616,300-9.9%	€23,998,008+6.9%	€22,442,276-39%	€36,804,037
	1.46-1.2%	1.47+7.9%	1.36+45.8%	0.94
	€9,843,244-13.3%	€11,353,838+38.7%	€8,186,973+448.4%	-€2,349,791
Efficiency
	59 days+6%	56 days-13.8%	65 days-4.5%	68 days
	26 days-20.2%	32 days-18.1%	39 days-30.7%	57 days
	23 days-8.7%	26 days+2.5%	25 days-18.7%	31 days
	13.53-9%	14.87+21.6%	12.23-8.5%	13.36
Profit appropriation
	€7,350,000+47.1%	€4,998,000	—	€4,140,500
	€306,2500%	€306,2500%	€306,2500%	€306,250
	€11,087,882+4.8%	€10,578,866+24.8%	€8,474,197>1000%	€4,100

2025

2024

2023

2022

Income statement

€123,219,725-11.4%

€139,082,750+3.4%

€134,532,319-0.1%

€134,623,404

€27,649,138-2.3%

€28,309,336+1.8%

€27,799,507-7.3%

€30,004,778

€11,226,853+9.4%

€10,262,874-11.8%

€11,642,314+74.5%

€6,670,410

€13,799,880

—

€9,156,775

€7,859,016+10.2%

€7,133,725-15.8%

€8,470,097+104.8%

€4,136,795

€1,864,306-42.5%

€3,241,858+16%

€2,795,521+315.8%

€672,265

Profitability

11.2%

—

6.8%

6.4%+24.4%

5.1%-18.5%

6.3%+104.9%

3.1%

54.4%+6.3%

51.1%-28.5%

71.5%-41.7%

122.6%

18.7%+15.1%

16.2%-22.8%

21.0%+134.7%

9.0%

Solvency

€42,072,932-4.3%

€43,945,624+9.1%

€40,285,224-12.8%

€46,176,887

€10,174,655+25%

€8,141,375-7.1%

€8,765,826-13.1%

€10,083,117

€438,733-3%

€452,403-49.2%

€890,148-45.7%

€1,639,524

€14,456,632+3.7%

€13,947,616+17.8%

€11,842,947+251.1%

€3,372,850

34.4%+8.3%

31.7%+8%

29.4%+302.5%

7.3%

€6,000,0000%

€6,000,000

0.42-3.5%

0.43-15.1%

0.51-71.5%

1.78

€27,616,300-7.9%

€29,998,008+5.5%

€28,442,276-33.5%

€42,804,037

1.91-11.2%

2.15-10.4%

2.40-81.1%

12.69

25.34+29.4%

19.59-20.3%

24.57+24.7%

19.71

Liquidity

—

€0

€5,242,546-23.6%

€6,865,746+8.9%

€6,303,536-28.1%

€8,769,723

€20,016,645-6.1%

€21,319,745-10.9%

€23,921,459-4.6%

€25,067,452

€6,816,705-33.1%

€10,196,707-15%

€12,000,661-35.9%

€18,722,992

€21,616,300-9.9%

€23,998,008+6.9%

€22,442,276-39%

€36,804,037

1.46-1.2%

1.47+7.9%

1.36+45.8%

0.94

€9,843,244-13.3%

€11,353,838+38.7%

€8,186,973+448.4%

-€2,349,791

Efficiency

59 days+6%

56 days-13.8%

65 days-4.5%

68 days

26 days-20.2%

32 days-18.1%

39 days-30.7%

57 days

23 days-8.7%

26 days+2.5%

25 days-18.7%

31 days

13.53-9%

14.87+21.6%

12.23-8.5%

13.36

Profit appropriation

€7,350,000+47.1%

€4,998,000

—

€4,140,500

€306,2500%

€306,250

€11,087,882+4.8%

€10,578,866+24.8%

€8,474,197>1000%

€4,100

MOLNLYCKE HEALTH CARE

Activities

Financials

Frequently asked questions

All locations

All locations